給 消 費 者 的 安 全 資 訊
>
引 致 更 改 給 病 人 的 產 品 資 訊 的 藥 物 不 良 反 應 警 示
引 致 更 改 給 病 人 的 產 品 資 訊 的 藥 物 不 良 反 應 警 示
Canada: Summary Safety Review - Finasteride and Dutasteride - Assessing the Potential Risk of Sexual Dysfunction (English only)
附件:
Finasteride
Related Information:
Canada: Summary Safety Review: Finasteride and Dutasteride: Assessing the potent...
上載於 2026-07-31
The United Kingdom: Finasteride and Dutasteride – updated safety warnings for ps...
上載於 2026-05-12
Measures to minimise risk of suicidal thoughts with finasteride and dutasteride ...
上載於 2025-05-09
European Union: Measures to minimise risk of suicidal thoughts with finasteride ...
上載於 2025-05-09
European Union: EMA has started a review of medicinal products containing finast...
上載於 2024-10-05
The United Kingdom: Finasteride reminder of the risk psychiatric side effects an...
上載於 2024-04-30
Canada: Summary Safety Review: Finasteride: Assessing the potential risks of sui...
上載於 2023-01-20
Finasteride: Assessing the potential risks of suicide, suicidal thoughts (suicid...
上載於 2023-01-20
Singapore: Finasteride and potential risk of suicidal ideation (English only)
上載於 2022-08-31
Canada: Summary Safety Review - Proscar and Propecia (finasteride) - Assessing t...
上載於 2019-02-27
英國:非那甾胺:抑鬱症及自殺念頭的罕見報告
上載於 2017-05-25
Finasteride: rare reports of depression and suicidal thoughts (Letter to Healthc...
上載於 2017-05-25